Cargando…
Mechanism and transmission routes of COVID-19
A recent form of novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged in China, appears to have a distinct genome from the previously sequenced coronavirus. SARS-CoV-2 is shown to cause acute respiratory infections in humans. SARS-CoV-2 is a ribonucleic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237516/ http://dx.doi.org/10.1016/B978-0-323-85780-2.00013-5 |
_version_ | 1783714743940284416 |
---|---|
author | Kirubananthan, Lokeshwaran Illuri, Ramanaiah Rajendran, Ramesh Chandrasekaran, Prasanna Raja |
author_facet | Kirubananthan, Lokeshwaran Illuri, Ramanaiah Rajendran, Ramesh Chandrasekaran, Prasanna Raja |
author_sort | Kirubananthan, Lokeshwaran |
collection | PubMed |
description | A recent form of novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged in China, appears to have a distinct genome from the previously sequenced coronavirus. SARS-CoV-2 is shown to cause acute respiratory infections in humans. SARS-CoV-2 is a ribonucleic acid virus believed to have transmitted from a zoonotic host accompanied by human-to-human spread that has contributed to a recent pandemic. Clinical symptoms of coronavirus disease 2019 patients start with tiredness, sore throat, cough, running nose, and fever, and then progressing to trouble breathing and loss of taste; severe cases experience death due to organ failure. Also, a few affected individuals can also be asymptomatic. Elderly and individuals with chronic conditions viz. hypertension, diabetes, and cardiac complications are more vulnerable to viral infection and disease severity. In this chapter, we discuss in detail the origin of SARS-CoV-2, followed by the various risk factors that could influence the infection, and finally the different modes of viral transmission. |
format | Online Article Text |
id | pubmed-8237516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-82375162021-06-28 Mechanism and transmission routes of COVID-19 Kirubananthan, Lokeshwaran Illuri, Ramanaiah Rajendran, Ramesh Chandrasekaran, Prasanna Raja Environmental and Health Management of Novel Coronavirus Disease (COVID-19 ) Article A recent form of novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged in China, appears to have a distinct genome from the previously sequenced coronavirus. SARS-CoV-2 is shown to cause acute respiratory infections in humans. SARS-CoV-2 is a ribonucleic acid virus believed to have transmitted from a zoonotic host accompanied by human-to-human spread that has contributed to a recent pandemic. Clinical symptoms of coronavirus disease 2019 patients start with tiredness, sore throat, cough, running nose, and fever, and then progressing to trouble breathing and loss of taste; severe cases experience death due to organ failure. Also, a few affected individuals can also be asymptomatic. Elderly and individuals with chronic conditions viz. hypertension, diabetes, and cardiac complications are more vulnerable to viral infection and disease severity. In this chapter, we discuss in detail the origin of SARS-CoV-2, followed by the various risk factors that could influence the infection, and finally the different modes of viral transmission. 2021 2021-06-28 /pmc/articles/PMC8237516/ http://dx.doi.org/10.1016/B978-0-323-85780-2.00013-5 Text en Copyright © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kirubananthan, Lokeshwaran Illuri, Ramanaiah Rajendran, Ramesh Chandrasekaran, Prasanna Raja Mechanism and transmission routes of COVID-19 |
title | Mechanism and transmission routes of COVID-19 |
title_full | Mechanism and transmission routes of COVID-19 |
title_fullStr | Mechanism and transmission routes of COVID-19 |
title_full_unstemmed | Mechanism and transmission routes of COVID-19 |
title_short | Mechanism and transmission routes of COVID-19 |
title_sort | mechanism and transmission routes of covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237516/ http://dx.doi.org/10.1016/B978-0-323-85780-2.00013-5 |
work_keys_str_mv | AT kirubananthanlokeshwaran mechanismandtransmissionroutesofcovid19 AT illuriramanaiah mechanismandtransmissionroutesofcovid19 AT rajendranramesh mechanismandtransmissionroutesofcovid19 AT chandrasekaranprasannaraja mechanismandtransmissionroutesofcovid19 |